natgillin/translations-raw huggingface dataset:
Instructions for handling and use
Navodila za uporabo
Instructions for health professionals
Navodila za zdravstveno osebje
Instructions for injecting Abseamed under the skin
Navodila za injiciranje zdravila Abseamed pod kožo
Instructions for injecting Binocrit under the skin
Navodila za injiciranje zdravila Binocrit pod kožo
Instructions for injecting Epoetin alfa HEXAL under the skin
Navodila za injiciranje zdravila Epoetin alfa HEXAL pod kožo
Instructions for injecting Herceptin using the administration system
Navodila za injiciranje zdravila Herceptin z uporabo aplikacijskega sistema
Instructions for injecting Plegridy
Navodila za injiciranje zdravila Plegridy
Instructions for injecting Plegridy BEFORE YOU START
Navodila za injiciranje zdravila Plegridy PRED ZAČETKOM
Instructions for injecting with the Aranesp pre-filled pen
Navodila za injiciranje z napolnjenim injekcijskim peresnikom Aranesp
Instructions for injecting with the Aranesp pre-filled pen (SureClick)
Navodila za injiciranje z napolnjenim injekcijskim peresnikom zdravila Aranesp (SureClick)
Instructions for injecting with the Aranesp pre-filled syringe
Navodila za injiciranje z napolnjeno injekcijsko brizgo Aranesp
Instructions for injecting with the Nespo pre-filled pen
Navodila za injiciranje z napolnjenim injekcijskim peresnikom Nespo
INSTRUCTIONS FOR INJECTING WITH THE NESPO PRE-FILLED PEN (SURECLICK)
NAVODILA ZA INJICIRANJE Z NAPOLNJENIM INJEKCIJSKIM PERESNIKOM NESPO (SURECLICK)
INSTRUCTIONS FOR INJECTING WITH THE NESPO PRE-FILLED SYRINGE
NAVODILA ZA INJICIRANJE Z NAPOLNJENO INJEKCIJSKO BRIZGO NESPA
Instructions for injecting with the Neupopeg pre-filled pen (SureClick)
Navodila za injiciranje Neupopega z uporabo napolnjenega injekcijskega peresnika (SureClick)
Instructions for injecting with the Neupopeg pre-filled syringe
Navodila za injiciranje Neupopega z uporabo napolnjene injekcijske brizge
Instructions for injecting with the Prolia pre-filled syringe
Navodila za injiciranje zdravila Prolia v napolnjeni injekcijski brizgi
Instructions for injecting Zinbryta How to inject Zinbryta
Navodila za injiciranje zdravila Zinbryta Kako injicirati zdravilo Zinbryta
Instructions for mixing and administration of the vaccine:
Navodila za mešanje in injiciranje cepiva
Instructions for opening and closing of the child-resistant box
navodila za odpiranje in zapiranje škatle, varne za otroke;
Instructions for opening and closing of the child-resistant box (for the multi-dose nasal spray) or the child resistant cap (for the multi-dose nasal spray DoseGuard) or opening of the blister (for the single-dose nasal spray)
Navodila za odpiranje in zapiranje za otroke varne škatle (za večodmerno pršilo za nos) ali za otroke varne zaporke (za večodmerno pršilo za nos DoseGuard) ali odpiranje pretisnega omota (za enoodmerno pršilo za nos)
Instructions for opening and closing of the child-resistant box (for the multi-dose nasal spray) or the child resistant cap (for the multi-dose nasal spray DoseGuard) or opening of the blister (for the single-dose nasal spray).
Navodila za odpiranje in zapiranje za otroke varne škatle (za večodmerno pršilo za nos) ali za otroke varne zaporke (za večodmerno pršilo za nos DoseGuard) ali odpiranje pretisnega omota (za enoodmerno pršilo za nos).
Instructions for opening and closing of the child-resistant box (for the multi-dose nasal spray) or the child resistant cap (for the multi-dose nasal spray DoseGuard) or opening of the blister (for the single-dose nasal spray).
Navodilu za odpiranje in zapiranje za otroke varne škatle (za večodmerno pršilo za nos) ali za otroke varne zaporke (za večodmerno pršilo za nos DoseGuard) ali odpiranju pretisnega omota (za enoodmerno pršilo za nos)
Instructions for opening the child-resistant blisters: Push the tablet for release from the blister.
Navodila za odpiranje za otroke varnih pretisnih omotov: Potisnite tableto, da se sprosti iz pretisnega omota.
Instructions for preparation
Navodila za pripravo.
Instructions for preparation and administration
Navodila za pripravo in aplikacijo
INSTRUCTIONS FOR PREPARATION AND ADMINISTRATION
NAVODILO ZA PRIPRAVO IN UPORABO
Instructions for preparation and handling and disposal
Navodila za pripravo in ravnanje z zdravilom ter odlaganje
Instructions for Preparation for Intravenous Administration for Cervical Cancer
Navodilo za pripravo za intravensko dajanje pri raku materničnega vratu
Instructions for Preparation for Intravenous Administration for Small Cell Lung Cancer
Navodilo za pripravo za intravensko dajanje pri drobnoceličnem pljučnem raku
Instructions for preparing and giving a subcutaneous injection of ORENCIA:
Navodila za pripravo in podkožno injiciranje zdravila ORENCIA:
Instructions for preparing and giving an injection of Cimzia
Navodila za pripravo in dajanje injekcij zdravila Cimzia
INSTRUCTIONS FOR PREPARING AND GIVING AN INJECTION OF CIMZIA PRE-FILLED PEN
NAVODILA ZA PRIPRAVO IN DAJANJE INJEKCIJ ZDRAVILA CIMZIA NAPOLNJENI INJEKCIJSKI PERESNIK
Instructions for preparing and giving an injection of Enbrel (See overleaf)
Navodila za pripravo in dajanje injekcije zdravila Enbrel (glejte drugo stran navodila)
Instructions for preparing and giving an injection of Enbrel (See overleaf).
Navodila za pripravo in dajanje injekcije zdravila Enbrel (glejte drugo stran navodila)
Instructions for preparing and giving an injection of Humira:
Navodila za pripravo in injiciranje zdravila Humira
Instructions for preparing reduced doses of Zoledronic Acid Accord: Withdraw the appropriate volume of the liquid concentrate, as follows:
Navodila za pripravo zmanjšanih odmerkov zdravila Zoledronska kislina Accord: Odvzemite ustrezni volumen tekočega koncentrata, kot sledi:
Instructions for preparing reduced doses of Zoledronic acid Actavis Withdraw an appropriate volume of the concentrate needed, as follows:
Navodila za pripravo zmanjšanih odmerkov zdravila Zoledronska kislina Actavis Izvlecite ustrezno količino potrebnega koncentrata:
Instructions for preparing reduced doses of Zoledronic acid Actavis: Withdraw the appropriate volume of the liquid concentrate, as follows:
Navodila za pripravo nižjih odmerkov zdravila Zoledronska kislina Actavis: Izvlecite ustrezno količino tekočega koncentrata:
Instructions for preparing reduced doses of Zoledronic Acid Hospira: Withdraw the appropriate volume of the liquid concentrate, as follows:
Navodila za pripravo zmanjšanih odmerkov zdravila Zoledronska kislina Hospira: Odvzemite ustrezni volumen tekočega koncentrata, kot sledi:
Instructions for preparing reduced doses of Zoledronic acid medac Withdraw an appropriate volume of the concentrate needed, as follows:
Navodila za pripravo zmanjšanih odmerkov zdravila Zoledronska kislina medac Odvzemite ustrezni volumen potrebnega koncentrata, kot sledi:
Instructions for preparing reduced doses of Zoledronic acid medac Withdraw an appropriate volume of the solution needed, as follows:
Navodila za pripravo zmanjšanih odmerkov zdravila Zoledronska kislina medac: Odvzemite ustrezni volumen potrebne raztopine, kot sledi:
Instructions for preparing reduced doses of Zoledronic acid Mylan Withdraw an appropriate volume of the concentrate needed, as follows:
Navodila za pripravo zmanjšanih odmerkov zdravila Zoledronska kislina Mylan Odvzemite ustrezni volumen potrebnega koncentrata, kot sledi:
Instructions for preparing reduced doses of Zoledronic acid Mylan: Withdraw the appropriate volume of the liquid concentrate, as follows:
Navodila za pripravo zmanjšanih odmerkov zdravila Zoledronska kislina Mylan: Odvzemite ustrezni volumen rekonstituirane raztopine (4 mg/5 ml), kot sledi:
Instructions for preparing reduced doses of Zoledronic Acid Teva: Withdraw the appropriate volume of the liquid concentrate, as follows:
Navodila za pripravo zmanjšanih odmerkov zdravila Zoledronska kislina Teva: Odvzemite ustrezni volumen tekočega koncentrata, kot sledi:
Instructions for proper use
Navodila za primerno ravnanje
Instructions for proper use
Navodila za ustrezno ravnanje:
Instructions for proper use in adults and adolescents (12 to less than 18 years of age)
Navodila za pravilno uporabo pri odraslih in mladostnikih (starih od 12 do manj kot 18 let)
Instructions for reconstitution
Navodila za rekonstitucijo raztopine
INSTRUCTIONS FOR RECONSTITUTION AND ADMINISTRATION
NAVODILO ZA PRIPRAVO IN UPORABO
Instructions for reconstitution and preparation of Kyprolis powder for solution for infusion for intravenous administration
Navodila za rekonstitucijo in pripravo zdravila Kyprolis prašek za raztopino za infundiranje za intravensko uporabo
Instructions for reconstitution of Cosentyx 150 mg powder for solution for injection:
Navodila za rekonstitucijo zdravila Cosentyx 150 mg prašek za raztopino za injiciranje:
Instructions for reconstitution of the vaccine with the solvent presented in ampoules:
Navodilo za rekonstitucijo cepiva, pri katerem je vehikel v napolnjeni injekcijski brizgi:
Instructions for reconstitution:
Navodila za rekonstitucijo
Instructions for taking INTELENCE for all patients
Navodila za jemanje zdravila INTELENCE za vse bolnike
Instructions for the preparation of 99mTc-depreotide:
Navodila za pripravo 99mTc-depreotida:
Instructions for use
Navodila za dajanje zdravila
INSTRUCTIONS FOR USE
NAVODILA ZA JEMANJE ZDRAVILA
Instructions for use
Navodila za uporabo.
INSTRUCTIONS FOR USE
NAVODILO ZA UPORABO ZDRAVILA
Instructions for use
Nosečnost
INSTRUCTIONS FOR USE
za injiciranje.
Instructions for use (see overleaf)
Navodila za pripravo (glejte drugo stran navodila)
Instructions for use (see overleaf)
Navodila za uporabo (glejte drugo stran navodila)
Instructions for use and handling
Navodila za uporabo in ravnanje z zdravilom
Instructions for use and handling - storage conditions
Navodila za uporabo in ravnanje z zdravilom – pogoji shranjevanja
Instructions for use and handling <and disposal>
Navodila za pripravo in ravnanje z zdravilom <in odlaganje>
Instructions for use and handling and special precautions for disposal
Posebni varnostni ukrepi za odstranjevanje in ravnanje z zdravilom
Instructions for use and handling – reconstitution, dilution and administration
Navodila za uporabo in ravnanje z zdravilom – rekonstitucija, redčenje in infundiranje
Instructions for use and handling – reconstitution, dilution and administration
Navodila za uporabo in ravnanje – pripravo, redčenje in dajanje
Instructions for use and handling – storage conditions
Navodila za uporabo in ravnanje z zdravilom – pogoji shranjevanja
Instructions for use and handling, and disposal
Navodila za pripravo in ravnanje z zdravilom in odlaganje
Instructions for use are included in the pack.
Navodila za uporabo so priložena v škatlici.
Instructions for Use Contents
Navodilo za uporabo Vsebina
Instructions for use for patients/ carers:
Navodila za uporabo za bolnike/skrbnike:
Instructions for use KwikPen
Navodila za uporabo peresnik KwikPen
Instructions for use of Cosentyx powder for solution for injection The following information is intended for medical or healthcare professionals only.
Navodila za uporabo praška za raztopino za injiciranje Cosentyx Naslednje informacije so namenjene samo zdravnikom oziroma zdravstvenemu osebju.
Instructions for use of fentanyl buccal tablet and how to place the tablet
Navodilih za uporabo bukalnih tablet s fentanilom in namestitev tablet
INSTRUCTIONS FOR USE OF ILARIS POWDER AND SOLVENT FOR SOLUTION FOR INJECTION (INJECTION KIT)
NAVODILA ZA UPORABO PRAŠKA IN VEHIKLA ZA RAZTOPINO ZA INJICIRANJE (KOMPLETA ZA INJICIRANJE) ZDRAVILA ILARIS
INSTRUCTIONS FOR USE OF ILARIS POWDER FOR SOLUTION FOR INJECTION
NAVODILA ZA UPORABO PRAŠKA ZA RAZTOPINO ZA INJICIRANJE ZDRAVILA ILARIS
INSTRUCTIONS FOR USE OF INSTANYL SINGLE-DOSE NASAL SPRAY
NAVODILO ZA UPORABO ZDRAVILA INSTANYL PRŠILO ZA NOS V ENOODMERNEM VSEBNIKU
Instructions for use of the nasal spray device
navodila za uporabo pripomočka za razprševanje v nos;
Instructions for use of the nasal spray device
Navodila za uporabo pršila za nos
Instructions for use of the nasal spray device
Navodila za uporabo pršila za nos.
Instructions for use of the nasal spray device
navodilih za uporabo pripomočka za razprševanje v nos;
Instructions for use of the nasal spray device.
Navodilu za uporabo pršila za nos
Instructions for use of Ultibro Breezhaler inhaler
Navodila za uporabo inhalatorja Ultibro Breezhaler
Instructions for use of Ulunar Breezhaler inhaler
Navodila za uporabo inhalatorja Ulunar Breezhaler
Instructions for use of Xoterna Breezhaler inhaler
Navodila za uporabo inhalatorja Xoterna Breezhaler
INSTRUCTIONS FOR USE Read the following instructions carefully before using your Actrapid FlexPen.
Preden uporabite zdravilo Actrapid FlexPen, natančno preberite ta navodila
INSTRUCTIONS FOR USE Read the following instructions carefully before using your Actrapid InnoLet.
Preden uporabite zdravilo Actrapid InnoLet, natančno preberite ta navodila
INSTRUCTIONS FOR USE Read the following instructions carefully before using your Mixtard 30 FlexPen.
Pred začetkom uporabe zdravila Mixtard 30 FlexPen natančno preberite navodilo.
INSTRUCTIONS FOR USE Read the following instructions carefully before using your Mixtard 30 InnoLet.
Pred začetkom uporabe zdravila Mixtard 30 InnoLet, natančno preberite navodilo.
Instructions for use Training
Navodilo za uporabo Usposabljanje
Instructions for Use – please be guided by the pictograms to understand how to use this product.
Navodila za uporabo – za navodila glede uporabe tega zdravila prosimo sledite slikovnim navodilom (piktogramom).
Instructions for use – preparation, handling and disposal
Navodila za uporabo – priprava, ravnanje in odstranjevanje
Instructions for use – reconstitution, dilution and administration
Navodila za uporabo – rekonstitucija, redčenje in dajanje zdravila
Instructions for use – reconstitution, dilution and administration
Navodila za uporabo – rekonstitucija, redčenje in uporaba
Instructions for use – see the end of this Package Leaflet for how to prepare and give the medicine
Navodila za pripravo in dajanje zdravila – najdete jih na koncu tega navodila
Instructions for use, handling and disposal
Navodila za pripravo, ravnanje in odlaganja zdravila
Instructions for use, handling and disposal
Navodila za uporabo, ravnanje z zdravilom in odlaganje
Instructions for Use.
Navodila za uporabo.
Instructions for use/and handling, and disposal
Posebni varnostni ukrepi za odstranjevanje in ravnanje z zdravilom Rekonstitucija‌
Instructions for use/handling INOmax
Navodila za pripravo/ravnanje z zdravilom INOmax
Instructions for use: Refer to Section 7 at the end of the package leaflet for instructions on how to use the Genuair inhaler.
Navodila za uporabo: Za navodila o uporabi inhalatorja Genuair glejte poglavje 7 na koncu navodil za uporabo.
INSTRUCTIONS FOR USING THE VICTOZA PEN
NAVODILA ZA UPORABO INJEKCIJSKEGA PERESNIKA VICTOZA
Instructions how to handle possible adverse events including providing of batch number when reporting adverse drug reactions
Navodila, kako obravnavati možne neželene učinke, vključno z zagotavljanjem številke serije pri poročanju neželenih reakcij zdravila.
Instructions in handling possible adverse events
navodilo za obravnavo možnih neželenih dogodkov,
Instructions of how to reconstitute and dilute INVANZ: For single use only.
Navodilo za pripravo in razredčevanje zdravila INVANZ: Samo za enkratno uporabo.
Instructions on how to dilute Rapamune
Navodila za razredčenje zdravila Rapamune
Instructions on how to dilute, store and dispose of Topotecan Teva General precautions
Navodila za redčenje, shranjevanje in odstranjevanje zdravila Topotekan Teva Slošni previdnostni ukrepi
Instructions on how to gently straighten your penis
Navodila za nežno ravnanje penisa
Instructions on how to gently stretch your penis
Navodila za nežno raztezanje penisa
Instructions on how to inject yourself
Navodila za samoinjiciranje
Instructions on how to inject yourself (for patients receiving chemotherapy or adult patients scheduled for orthopaedic surgery only)
Navodila za samoinjiciranje (samo za bolnike, ki prejemajo kemoterapijo, ali odrasle bolnike, naročene na ortopedski kirurški poseg)
Instructions on how to inject yourself (for patients with symptomatic anaemia caused by kidney disease, for patients receiving chemotherapy or adult patients scheduled for orthopaedic surgery only)
Navodila za samoinjiciranje (samo za bolnike s simptomatsko anemijo, ki jo povzroči bolezen ledvic, za bolnike, ki prejemajo kemoterapijo, ali odrasle bolnike, naročene na ortopedski kirurški poseg)
Instructions on how to open the child-resistant blister
Navodilih o odpiranju za otroke varnega pretisnega omota
Instructions on how to reconstitute, store and dispose of Hycamtin Reconstitution
Navodila za rekonstitucijo, shranjevanje in odstranjevanje zdravila Hycamtin Rekonstitucija
INSTRUCTIONS ON HOW TO STORE AND DISPOSE OF ATRIANCE
NAVODILA ZA SHRANJEVANJE IN ODSTRANJEVANJE ZDRAVILA ATRIANCE
Instructions on how to use NovoEight
Navodila za uporabo zdravila NovoEight
Instructions on how to use NovoRapid solution for injection in InnoLet
Navodila za uporabo zdravila NovoRapid raztopina za injiciranje v injekcijskem peresniku
Instructions on how to use NovoSeven
Navodila za uporabo zdravila NovoSeven
Instructions on injecting yourself with Inhixa
Kako si sami injicirate zdravilo Inhixa
Instructions on injecting yourself with Thorinane
Kako si sami injicirate zdravilo Thorinane
Instructions on management of adverse events based on monitoring and dose modifications or treatment withdrawal.
Navodila o obravnavi neželenih učinkov na podlagi spremljanja in prilagajanja odmerka ali ukinitve zdravljenja.
Instructions on the correct dose to be administered
navodila o pravilnem odmerku, ki naj ga prejema bolnik,
Instructions on the rate of infusion are shown in Tables 5 and 6.
Navodila glede hitrosti infundiranja so prikazana v preglednicah 5 in 6.
Instructions on the safe use (to avoid the risk of overdosing), on storage (to avoid the risk of accidental exposure), and disposal of fentanyl buccal tablet
Navodil o varni uporabi (v izogib tveganju prevelikega odmerjanja), shranjevanju (v izogib tveganju nezgodne izpostavitve) in odstranjevanja bukalnih tablet s fentanilom
Instructions on the use of the creatinine clearance slide ruler
Navodila o uporabi drsnega ravnila za očistek kreatinina.
INSTRUCTIONS ON USE
IME IMETNIKA DOVOLJENJA ZA PROMET Z ZDRAVILOM
INSTRUCTIONS ON USE
IME ZDRAVILA
INSTRUCTIONS ON USE
NOTKUNARLEIÐBEININGAR
INSTRUCTIONS ON USE
PODATKI NA ZUNANJI OVOJNINI
INSTRUCTIONS ON USE
PODATKI V BRAILLOVI PISAVI
INSTRUCTIONS ON USE
POSEBNA NAVODILA ZA SHRANJEVANJE
INSTRUCTIONS ON USE
Pred uporabo preberite priloženo navodilo.
INSTRUCTIONS ON USE
Za peroralno uporabo.
Instructions on use of the graduated syringe
navodila za uporabo odmerne injekcijske brizge,
Instructions overleaf 
Navodila na hrbtni strani 
Instructions precautions for disposal and other handling
Posebni varnostni ukrepi za odstranjevanje in ravnanje z zdravilom
Instructions reinforcing that the indicated age range is 13-17 years and that aripiprazole is not recommended for use in patients below 13 years of age due to safety concerns
Navodilo, ki naj poudari, da je starostna meja za to indikacijo 13-17 let in da se uporabe aripiprazola pri bolnikih, mlajših od 13 let, zaradi skrbi glede varnosti zdravila pri teh bolnikih, ne priporoča.
Instructions that the recommended dose is 10 mg/day and that enhanced efficacy at higher doses has not been demonstrated
Navodilo, da je priporočeni odmerek 10 mg/dan in da večja učinkovitost pri uporabi višjih odmerkov ni dokazana.
Instructions to change and rotate the site of injection for each injection to avoid the development of lipohypertrophy.
Navodila za spreminjanje in menjavanje vbodnega mesta za vsako injekcijo, z namenom izogiba razvoja lipohipertrofije.
Instructions to minimise the risk of exposure of blood and body fluids to close contacts for the duration of IMLYGIC treatment through 30 days after the last administration of IMLYGIC.
Navodila za zmanjšanje tveganja za izpostavljenost krvi in telesnih tekočin osebam, ki so v tesnem stiku z bolnikom, za čas trajanja zdravljenja z zdravilom IMLYGIC in še 30 dni po zadnjem dajanju zdravila IMLYGIC.
Instructions to provide patients and caregivers with the patient reminder card The patient reminder card should contain the following key messages:
Navodila za izročanje opozorilne kartice za bolnika bolnikom in negovalcem Opozorilna kartica za bolnika mora vsebovati naslednja ključna sporočila:
Instructions to reconstitute the oral suspension
Navodila za rekonstitucijo peroralne suspenzije
Instructions to report the onset or worsening of snoring that may indicate an increase in growth of tonsils and/or adenoids following the beginning of treatment with INCRELEX.
Navodila za poročanje o pojavu ali poslabšanju smrčanja, kar lahko nakazuje povečano rast tonzil in/ali adenoidnega tkiva kot posledico začetka zdravljenja z zdravilom INCRELEX.
Instructions to stop pomalidomide immediately upon suspicion of pregnancy
navodila za takojšnjo prekinitev zdravljenja s pomalidomidom pri sumu na nosečnost,
Instrumentation
instrumenti,
Instruments must be linear over a wide range of CO2 concentrations typically 1.0 - 6.0%.
Instrumenti morajo meriti linearno na širokem območju koncentracij CO2 (običajno 1,0 - 6,0 %).
Insufficient circulation
nezadostna cirkulacija
Insufficient data are available for infants who have a post- conceptual age of less than 36 weeks.
Na voljo ni dovolj podatkov za dojenčke s postkoncepcijsko starostjo manj kot 36 tednov.
Insufficient data are available to make a recommendation for patients with a creatinine clearance < 20 ml/min.
Za zdravljenje bolnikov z očistkom kreatinina < 20 ml/min ni možno priporočiti ustreznih odmerkov, saj obstaja premalo izkušenj.
Insufficient data are available to make a recommendation for patients with a creatinine clearance <20 ml/min.
Za zdravljenje bolnikov z očistkom kreatinina < 20 ml/min ne moremo priporočiti ustreznih odmerkov, saj imamo premalo izkušenj.
Insufficient data to recommend dosage
Za priporočilo o prilagoditvi odmerjanja
Insufficient evidence
nezadostni dokazi
insufficient function of the kidneys, reduced production of urine, impaired or painful urination
nezadostno delovanje ledvic, zmanjšano nastajanje seča, oslabljeno ali boleče uriniranje
Insufficient function of the kidneys, reduced production of urine, impaired or painful urination
nezadostno delovanje ledvic, zmanjšano nastajanje urina, oslabljeno ali boleče uriniranje,
Insufficient pharmacokinetic data is available for other ethnicities or races.
O uporabi zdravila pri pripadnikih drugih etničnih skupin ali ras ni na voljo dovolj farmakokinetičnih podatkov.
insufficient production of thyroid hormone
nezadostno nastajanje ščitničnega hormona
Insufficient safety data are available for children below 18 years of age.
Za otroke stare do 18 let so podatki o varnosti nezadostni.
Insufficient virologic response
Nezadosten virološki odziv
Insulatard contains insulin mixed with another substance, protamine, in an ‘isophane’ form which is absorbed much more slowly during the day.
V zdravilu Insulatard je insulin zmešan z drugo snovjo, tj. protaminom, v obliki „izofan“, ki se čez dan absorbira mnogo počasneje.
Insulatard human insulin
Insulatard humani insulin
INSULATED POLYURETHANE CONTAINER
IZOLIRANI POLIURETANSKI VSEBNIK
Insulin
insulinsko okence
Insulin
preostanka
Insulin absorption and hence the blood-glucose-lowering effect of a dose may vary from one injection area to another (e.g. the abdominal wall compared with the thigh).
Absorpcija insulina – in s tem njegov hipoglikemični učinek – se lahko razlikuje od enega predela injiciranja do drugega (npr. trebušna stena v primerjavi s stegnom).
Insulin absorption and hence the blood–glucose-lowering effect of a dose may vary from one injection area to another (e.g. the abdominal wall compared with the thigh).
Absorpcija insulina – in s tem njegov hipoglikemični učinek – se lahko razlikuje od enega predela injiciranja do drugega (npr. trebušna stena v primerjavi s stegnom).